CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- 4 Open-market sale Chief Commercial Officer sold 38,262 shares at $4.83 ($184,805)
- 4 Open-market sale President and CEO sold 50,677 shares at $4.83 ($244,770)
- 4 Open-market buy Director bought 200,000 shares at $5.02 ($1,004,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy President and CEO bought 7,500 shares at $2.10 ($15,750)
- 4 Open-market buy Chief Legal Officer bought 7,500 shares at $3.40 ($25,500)
- 4 Open-market buy 10% owner bought 1,428,571 shares at $2.10 ($2,999,999)
- 4 Open-market buy Chief Legal Officer bought 5,714 shares at $2.10 ($11,999)
- 4 Open-market buy President and CEO bought 23,809 shares at $2.10 ($49,999)
- 4 Open-market buy Chief Medical Officer bought 23,809 shares at $2.10 ($49,999)
- 4 Open-market buy Director bought 238,095 shares at $2.10 ($500,000)
- 4 Open-market buy Director bought 4,761,904 shares at $2.10 ($9,999,998)
Page 5 of 13 · 253 filings